Home › Ductal Carcinoma In Situ (DCIS) › NCT05178498

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Longitudinal Study Evaluating the Impact of Dietary Inflammatory Potential on Breast Cancer Risk in a Cohort of Women Followed in the Breast Cancer Prevention Clinic at the Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Age \>= 18 years
* Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer \[BC\], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ \[LCIS\], or prior chest wall radiation)
* Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)
* Able to read and understand English
* Able to provide informed consent
* Must consent to continued follow-up of medical records during the study period

Exclusion Criteria:

* Prisoners
* Not able to speak and understand English
* Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC

About the study

This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.

What is being tested

• Follow-Up (procedure)
• Physical Examination (procedure)
• Questionnaire Administration (other)

Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 960 · Started: Oct 25, 2023

Contact the study team

• The Ohio State University Comprehensive Cancer Center · Phone: 800-293-5066

Official record on ClinicalTrials.gov — NCT05178498

Locations in the U.S.

Conditions

• Ductal Carcinoma In Situ (DCIS)
• Breast Cancer
• Breast Carcinoma In Situ

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.